Peritoneal Carcinomatosis Risk and Long-Term Survival Following Hepatectomy for Spontaneous Hepatocellular Carcinoma Rupture: Results of a Multicenter French Study (FRENCH—AFC)
Autor: | Astrid Herrero, Daniel Cherqui, Michael Bubenheim, Jean-Yves Mabrut, Emmanuel Boleslawski, Emilie Lermite, L. Schwarz, Edouard Roussel, Yves-Patrice Le Treut, Fabrice Muscari, Alexis Laurent, Alexandre Doussot, Romain Riboud, Ahmet Ayav, Jean-Marc Regimbeau, Eric Savier |
---|---|
Přispěvatelé: | Hôpital Charles Nicolle [Rouen], Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Saint Eloi (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CHU Toulouse [Toulouse], Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Claude Huriez [Lille], CHU Lille, Centre Hospitalier Universitaire de Nancy (CHU Nancy), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), CHU Amiens-Picardie, Centre Hospitalier Universitaire [Grenoble] (CHU), Hôpital Paul Brousse, Centre Universitaire des Maladies Rénales [CHU Caen] (CUMR Caen), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), CHU Rouen |
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty Carcinoma Hepatocellular [SDV]Life Sciences [q-bio] medicine.medical_treatment 030230 surgery Gastroenterology 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine medicine Carcinoma Hepatectomy Humans Risk factor Peritoneal Neoplasms Survival analysis Aged Retrospective Studies Rupture Spontaneous business.industry Mortality rate Liver Neoplasms Retrospective cohort study Middle Aged Prognosis medicine.disease Survival Analysis Treatment Outcome Italy Oncology 030220 oncology & carcinogenesis Hepatocellular carcinoma Female Surgery France Neoplasm Recurrence Local Complication business |
Zdroj: | Annals of Surgical Oncology Annals of Surgical Oncology, Springer Verlag, 2020, 27 (9), pp.3383-3392. ⟨10.1245/s10434-020-08442-5⟩ |
ISSN: | 1534-4681 1068-9265 |
DOI: | 10.1245/s10434-020-08442-5 |
Popis: | International audience; Background: Spontaneous rupture of hepatocellular carcinoma (HCC) remains a life-threatening complication, with a reported mortality rate of between 16 and 30% and an incidence rate of approximately 3% in Europe. Survival data and risk factors after ruptured HCC are lacking, especially for peritoneal metastasis (PM).Objectives: The aims of this study were to evaluate the pattern of recurrence and mortality after hepatectomy for ruptured HCC, and to focus on PM.Methods: We retrospectively reviewed the files of patients admitted to 14 French surgical centers for spontaneous rupture of HCC between May 2000 and May 2012.Results: Overall, 135 patients were included in this study. The median disease-free survival and overall survival (OS) rates were 16.1 (11.0-21.1) and 28.7 (26.0-31.5) months, respectively, and the median follow-up period was 29 months. At last follow-up, recurrences were observed in 65.1% of patients (n = 88). The overall rate of PM following ruptured HCC was 12% (n = 16). Surgical management of PM was performed for six patients, with a median OS of 36.6 months. An α-fetoprotein level > 30 ng/mL (p = 0.0009), tumor size at rupture > 70 mm (p = 0.0009), and vascular involvement (p < 0.0001) were found to be independently associated with an increased likelihood of recurrence. No risk factor for PM was observed.Conclusion: This large-cohort French study confirmed that 12% of patients had PM after ruptured HCC. A curative approach may be an option for highly selected patients with exclusive PD because of the survival benefit it could provide. |
Databáze: | OpenAIRE |
Externí odkaz: |